Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566536746> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2566536746 endingPage "4375" @default.
- W2566536746 startingPage "4375" @default.
- W2566536746 abstract "Abstract DRI incorporates both disease type and status at transplant and was found to be strong independent predictor of survival after allogeneic (allo) hematopoietic cell transplantation (HCT). Using the refined DRI assignment, we compared survival outcomes of UCB transplant (n=548: 314 with 5-6/6 and 231 with 4/6 HLA-matched units) to 8/8 HLA-matched adult donor HCT (n=528: 446 sibling and 82 unrelated; 78 bone marrow [BM] and 450 peripheral blood [PB] grafts) for hematological malignancies from 2000-2013. UCB and adult (BM/PB) groups had similar patient and transplant characteristics except UCB patients were slightly younger (47.5 year vs. 50.5 year; p <0.01), had more comorbid conditions at HCT (37.0% vs. 28.2% HCT-CI ≥3; p =0.03), and were more likely to receive reduced intensity conditioning regimen (67.7% vs. 55.9%; p <0.01). Three DRI groupings were identified: low risk (LR, 83 UCB and 110 BM/PB), intermediate risk (IR, 369 UCB and 329 PB) and high/very high risk (HR, 96 UCB and 89 BM/PB) groups. Adjusted estimates of OS at 2 years were similar with UCB or adult donors for all DRI groups (Figure). Multiple regression analysis compared outcomes of UCB with matched adult donor in each DRI group (Table). After adjusting for age and conditioning, grade III-IV acute GVHD incidence in all DRI groups was similar with both donor types. In contrast, UCB resulted in significantly lower rates of chronic GVHD in all DRI groups. Importantly, donor type was not an independent predictor of either TRM or relapse in any DRI group. In the LR-DRI group DFS was inferior with UCB, but in IR- and HR-DRI donor type had no influence on DFS after adjusting for comorbidities and CMV serostatus. Our data demonstrates that UCB is a valid alternative donor type for alloHCT, particularly those with IR and HR DRI. UCB grafts yield survival similar to matched adult donor alloHCT when DRI is considered. Low chronic GVHD risk makes UCB particularly attractive graft source for older patients. Table 1. Adjusted clinical outcomes by graft source based on DRI DRIGroup Graft Source N aGVHD Grade III-IV cGVHD TRM Relapse DFS OS HR(95%CI) P HR (95%CI) P RR (95%CI) P RR (95%CI) P HR* (95%CI) P HR† (95%CI) P Low risk BM/PB UCB 110 83 1.0 0.68 (0.36-1.26) .82 1.0 0.32 (0.18-0.57) <.01 1.0 1.47 (0.72-3.00) .29 1.0 1.83 (0.96-3.48) .07 1.0 1.70 (1.06-2.72) .03 1.0 1.34 (0.75-2.41) .32 Intermediate Risk BM/PB UCB 329 369 1.0 1.01 (0.73-1.39) .96 1.0 0.50 (0.38-0.67) <.01 1.0 1.08 (0.76-1.52) .66 1.0 0.95 (0.72-1.26) .74 1.0 0.91 (0.74-1.14) .42 1.0 1.17 (0.91-1.50) .23 High/very- high risk BM/PB UCB 89 96 1.0 0.75 (0.39-1.45) .40 1.0 0.76 (0.60-0.96) .02 1.0 1.57 (0.85-2.90) .15 1.0 0.68 (0.41-.110) .12 1.0 1.06 (0.73-1.54) .76 1.0 1.36 (0.90-2.06) .15 HR indicates hazard ratio; RR, relative risk. *Denotes hazard ratio of death/relapse. †Denotes hazard ratio of death. Figure 1. Figure 1. Disclosures Bachanova: Seattle Genetics Inc.: Consultancy, Research Funding." @default.
- W2566536746 created "2017-01-06" @default.
- W2566536746 creator A5008157848 @default.
- W2566536746 creator A5009609420 @default.
- W2566536746 creator A5009719497 @default.
- W2566536746 creator A5035807701 @default.
- W2566536746 creator A5040328429 @default.
- W2566536746 creator A5054714265 @default.
- W2566536746 creator A5061692821 @default.
- W2566536746 creator A5065360941 @default.
- W2566536746 creator A5067489954 @default.
- W2566536746 creator A5070132319 @default.
- W2566536746 creator A5071407391 @default.
- W2566536746 creator A5087156523 @default.
- W2566536746 date "2015-12-03" @default.
- W2566536746 modified "2023-10-16" @default.
- W2566536746 title "Similar Survival after Umbilical Cord Blood (UCB) and HLA-Matched Adult Donor Transplantation By Disease Risk Index (DRI) Assignment" @default.
- W2566536746 doi "https://doi.org/10.1182/blood.v126.23.4375.4375" @default.
- W2566536746 hasPublicationYear "2015" @default.
- W2566536746 type Work @default.
- W2566536746 sameAs 2566536746 @default.
- W2566536746 citedByCount "3" @default.
- W2566536746 countsByYear W25665367462017 @default.
- W2566536746 countsByYear W25665367462018 @default.
- W2566536746 countsByYear W25665367462022 @default.
- W2566536746 crossrefType "journal-article" @default.
- W2566536746 hasAuthorship W2566536746A5008157848 @default.
- W2566536746 hasAuthorship W2566536746A5009609420 @default.
- W2566536746 hasAuthorship W2566536746A5009719497 @default.
- W2566536746 hasAuthorship W2566536746A5035807701 @default.
- W2566536746 hasAuthorship W2566536746A5040328429 @default.
- W2566536746 hasAuthorship W2566536746A5054714265 @default.
- W2566536746 hasAuthorship W2566536746A5061692821 @default.
- W2566536746 hasAuthorship W2566536746A5065360941 @default.
- W2566536746 hasAuthorship W2566536746A5067489954 @default.
- W2566536746 hasAuthorship W2566536746A5070132319 @default.
- W2566536746 hasAuthorship W2566536746A5071407391 @default.
- W2566536746 hasAuthorship W2566536746A5087156523 @default.
- W2566536746 hasConcept C120665830 @default.
- W2566536746 hasConcept C121332964 @default.
- W2566536746 hasConcept C126322002 @default.
- W2566536746 hasConcept C141071460 @default.
- W2566536746 hasConcept C203014093 @default.
- W2566536746 hasConcept C2776955114 @default.
- W2566536746 hasConcept C2777408962 @default.
- W2566536746 hasConcept C2911091166 @default.
- W2566536746 hasConcept C61511704 @default.
- W2566536746 hasConcept C71924100 @default.
- W2566536746 hasConcept C90924648 @default.
- W2566536746 hasConceptScore W2566536746C120665830 @default.
- W2566536746 hasConceptScore W2566536746C121332964 @default.
- W2566536746 hasConceptScore W2566536746C126322002 @default.
- W2566536746 hasConceptScore W2566536746C141071460 @default.
- W2566536746 hasConceptScore W2566536746C203014093 @default.
- W2566536746 hasConceptScore W2566536746C2776955114 @default.
- W2566536746 hasConceptScore W2566536746C2777408962 @default.
- W2566536746 hasConceptScore W2566536746C2911091166 @default.
- W2566536746 hasConceptScore W2566536746C61511704 @default.
- W2566536746 hasConceptScore W2566536746C71924100 @default.
- W2566536746 hasConceptScore W2566536746C90924648 @default.
- W2566536746 hasIssue "23" @default.
- W2566536746 hasLocation W25665367461 @default.
- W2566536746 hasOpenAccess W2566536746 @default.
- W2566536746 hasPrimaryLocation W25665367461 @default.
- W2566536746 hasRelatedWork W2086149900 @default.
- W2566536746 hasRelatedWork W2154341374 @default.
- W2566536746 hasRelatedWork W2318530450 @default.
- W2566536746 hasRelatedWork W2357142827 @default.
- W2566536746 hasRelatedWork W2359804617 @default.
- W2566536746 hasRelatedWork W2365848850 @default.
- W2566536746 hasRelatedWork W2392641532 @default.
- W2566536746 hasRelatedWork W2442220036 @default.
- W2566536746 hasRelatedWork W2590929729 @default.
- W2566536746 hasRelatedWork W2114487924 @default.
- W2566536746 hasVolume "126" @default.
- W2566536746 isParatext "false" @default.
- W2566536746 isRetracted "false" @default.
- W2566536746 magId "2566536746" @default.
- W2566536746 workType "article" @default.